Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Vor Biopharma Inc.

NASDAQ: VOR · Life Sciences · 2 alerts · CIK 1817229

Share price
$18.97Close, Nov 16
Market cap
$1.17B
Shares outstanding
61.43MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Vor Biopharma Inc. filings on SEC EDGAR ↗

8:01 AM ET 10-Q
Financial Results

Vor Biopharma Q3 2026 Results: Net Loss of $86.7M, Loss Narrows

Vor Biopharma Inc. is a clinical-stage biotechnology company that remains pre-revenue, incurring significant net losses since inception. The company is focused on the development of its lead product candidate, telitacicept, and expects to require substantial additional funding to support ongoing research and clinical trials.

Key figure
Net loss $86.7M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.